Concepedia

Stephen L. Atkin

SL

259

Publications

17.4K

Citations

63

H-Index

1986

Active since

Affiliations

University of Hull(Current)

Hull York Medical School

Hull Royal Infirmary

Weill Cornell Medical College in Qatar

Royal College of Surgeons in Ireland - Bahrain

Stephen L. Atkin is an author at University of Hull specializing in medicine, metabolic syndrome, and diabetes.

ORCID

Top concepts

Publications per year

1986–2025

259

Publications

259

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes

Eric S. Kilpatrick, Alan S. Rigby, Stephen L. Atkin · Diabetes Care · 2007 · 428 citations · Full text

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes

Eric S. Kilpatrick, Alan S. Rigby, Stephen L. Atkin · Diabetes Care · 2008 · 410 citations · Full text

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes

Eric S. Kilpatrick, Alan S. Rigby, Stephen L. Atkin · Diabetes Care · 2006 · 374 citations · Full text

Rows per page

1–5 of 259